377 related articles for article (PubMed ID: 28127506)
1. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
Banach M; Juranek JK; Zygulska AL
Brain Behav; 2017 Jan; 7(1):e00558. PubMed ID: 28127506
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.
Zajączkowska R; Kocot-Kępska M; Leppert W; Wrzosek A; Mika J; Wordliczek J
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909387
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Verstappen CC; Heimans JJ; Hoekman K; Postma TJ
Drugs; 2003; 63(15):1549-63. PubMed ID: 12887262
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced peripheral neuropathy: A current review.
Staff NP; Grisold A; Grisold W; Windebank AJ
Ann Neurol; 2017 Jun; 81(6):772-781. PubMed ID: 28486769
[TBL] [Abstract][Full Text] [Related]
6. [Neurotoxic effects of medications: an update].
Arné-Bès MC
Rev Med Liege; 2004; 59 Suppl 1():118-23. PubMed ID: 15244167
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
8. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.
Grisold W; Cavaletti G; Windebank AJ
Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv45-54. PubMed ID: 23095830
[TBL] [Abstract][Full Text] [Related]
9. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment.
Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
Beijers AJ; Jongen JL; Vreugdenhil G
Neth J Med; 2012 Jan; 70(1):18-25. PubMed ID: 22271810
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and peripheral neuropathy.
Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB
Neurol Sci; 2021 Oct; 42(10):4109-4121. PubMed ID: 34436727
[TBL] [Abstract][Full Text] [Related]
12. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
13. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Curr Opin Neurol; 2015 Oct; 28(5):500-7. PubMed ID: 26197027
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced neuropathy.
Windebank AJ; Grisold W
J Peripher Nerv Syst; 2008 Mar; 13(1):27-46. PubMed ID: 18346229
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.
Pellacani C; Eleftheriou G
Adv Med Sci; 2020 Sep; 65(2):265-285. PubMed ID: 32361484
[TBL] [Abstract][Full Text] [Related]
17. Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).
Pachman DR; Qin R; Seisler DK; Smith EM; Beutler AS; Ta LE; Lafky JM; Wagner-Johnston ND; Ruddy KJ; Dakhil S; Staff NP; Grothey A; Loprinzi CL
J Clin Oncol; 2015 Oct; 33(30):3416-22. PubMed ID: 26282635
[TBL] [Abstract][Full Text] [Related]
18. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
19. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
20. Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.
Smith EML; Kuisell C; Kanzawa-Lee GA; Bridges CM; Alberti P; Cavaletti G; Saad R; Park S;
Lancet Haematol; 2020 May; 7(5):e408-e417. PubMed ID: 32359452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
